Omeza OCM™

Wound Care Matrix

Box of OMC wound care matrix medical device with hexagon design and sterile label.

FIRST OF ITS KIND 510(k) DRUG/DEVICE

Delivering complete and personalized therapy to address all phases of wound healing (A2014)

A thermometer with the brand name 'OMEZÁ' in front of sliced bananas.

What is OCM™?

OCM™ is a novel, proprietary technology, providing pharmaceutical grade time-released elements that migrate into the tunnels and crevices of the wound bed to support each stage of wound healing

  • OCM™ is an amorphous solid made with cold water fish peptides. OCM™ provides scaffolding for skin to regrow on and provides molecules which signal tissues to grow

  • OCM™ is a sterile single use drug/device product that is absorbable and biodegradable over time

  • OCM™ covers the entire wound, providing a physical barrier and protective environment to support the healing process

Decrease Inflamation

+

Increase Proliferation

+

Support Remodeling

+

Reduce Biofilm Impact

+

Decrease Inflamation + Increase Proliferation + Support Remodeling + Reduce Biofilm Impact +

Top 10 Overview

  • OCM is described as a first-of-its-kind, drug-device combination product, offering a multimodal therapy designed to address all phases of wound healing, which is distinct from many products that focus on a single aspect (e.g., just an antimicrobial barrier or just a collagen scaffold).

  • The matrix is made of cold water hydrolyzed fish peptides (specifically whitefish skin-derived, often type I, II, III, IV) infused with cod liver oil (a source of Omega-3s) and other plant-derived oils and waxes, which is a key differentiator from matrices derived from porcine, bovine, or amniotic tissue.

  • The inclusion of pharmaceutical-grade Omega-3 fatty acids (from cod liver oil) is a unique feature that helps to decrease chronic inflammation in the wound bed, a critical issue in non-healing chronic wounds.

  • The product is specifically designed and cited in studies to reduce the impact of biofilm formation and bacterial contamination, offering a multimodal approach to managing microbial burden that does not contain an antiseptic or disinfectant.

  • OCM provides a comprehensive, four-pronged approach—reducing inflammation, reducing biofilm impact, increasing proliferation, and supporting remodeling—covering the entire wound healing cascade, unlike simpler dressings or single-action components.

  • It provides pharmaceutical-grade time-released elements that are designed to migrate into the tunnels and crevices of the wound bed, supporting healing even in irregular or undermined wounds, offering a more intimate contact than sheet or simpler gel matrices.

  • The formulation incorporates cod liver oil that acts as an anhydrous skin protectant, which helps protect the surrounding skin and maintain a favorable wound environment while supplementing the collagen matrix.

  • OCM is supplied in single-use, disposable vials and is formulated to be an easily applied topically with no additional preparation (like hydration with saline) or special equipment (like refrigeration) required, simplifying the protocol for healthcare professionals.

  • Its malleable, particle-based nature allows the matrix to intimately conform to both regular and irregular wound beds, ensuring complete coverage and protection, which is a significant advantage over rigid or sheet-style matrices.

  • Certified by the Marine Stewardship Council. Manufactured in the USA.

Indications For Use

  • Partial and Full Thickness Wounds

  • Pressure Ulcers

  • Venous Ulcers

  • Diabetic Ulcers

  • Chronic Vascular Ulcers

  • Tunneled/Undermined Wounds

  • Surgical Wounds

  • Trauma Wounds

  • Draining Wounds

Contraindications

  • Known sensitivity to fish collagen or cod liver oil

  • 3rd Degree Burns

Case Studies

Photographs showing healing progress of various wounds over weeks. The first row documents a diabetic foot ulcer with charcot deformity healing from week 1 to week 9. The second row shows a venous leg ulcer healing from initial state to week 5. The third row depicts a tunneling abdominal wound healing from week 1 to week 11.